We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Topical Growth Factors / EGF cosmeceuticals
'Regenerative' anti-aging serums built around growth factors and cytokines (from human fibroblast cultures, EGF, or snail/plant sources) applied to the skin. The honest framing: growth factors genuinely stimulate fibroblasts and collagen, and small studies report modest wrinkle/texture improvements — but the evidence is weak. The strongest synthesis (a 33-study review) found three head-to-head RCTs with no significant benefit over control, the human trials are mostly small, open-label, and manufacturer-funded, and these are large proteins that may not penetrate intact skin. Biologically plausible, commercially popular, but only low-grade and partly subjective support.
Topical cosmetic ingredient — not a dietary supplement
Growth Factors (topical) is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most Growth Factors (topical) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2008–2023 with a typical study size of 50 participants.
Based on 6 studies · 2 RCTs · 142 total participants
Confidence
Low confidenceBy outcome
Biologically plausible (growth factors stimulate fibroblasts/collagen) with some consistent low-grade signal, but the strongest review found three head-to-head RCTs with no significant benefit, human data are mostly small/open-label/manufacturer-funded, and large growth-factor proteins may not penetrate intact skin.
16 trials ongoing or recruiting · 41 completed on ClinicalTrials.gov
12 of the completed trials have posted results
Registered trials show research momentum for Growth Factors (topical), not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Aug 2026
Topical growth-factor cosmeceuticals are 'regenerative' anti-aging serums whose active fraction is a mixture of growth factors and cytokines — commonly secreted by cultured human dermal fibroblasts (conditioned media), or epidermal growth factor (EGF), or growth-factor-rich secretions from snails or plants.
This entry covers topical use. The rationale is real: growth factors (EGF, TGF-beta, VEGF) control cell proliferation and differentiation, and skin wound-healing pathways overlap with those implicated in photoaging, so stimulating fibroblasts to make collagen is plausible. But the evidence is weak.
A double-blind vehicle-controlled trial of a >110-growth-factor fibroblast serum (Mehta et al., 2008; n=60) reported greater wrinkle/fine-line reduction than vehicle, though results were 'significant or trending toward significance' and the study was manufacturer-conducted.
The strongest synthesis — a systematic review of 33 studies (9 RCTs, 24 uncontrolled series; Quinlan et al., 2023) — found only modest, largely subjective improvements (texture median <50%, wrinkles <35%) and, critically, three comparative RCTs with no significant difference between treatments.
Small open-label pilots (Hussain 2008, n=14; Seidel & Moy 2015, n=18) report wrinkle/under-eye improvements but lack controls, and even a vehicle-controlled snail-growth-factor RCT (Lim 2020) saw vehicle improve wrinkles as much as active on the headline endpoint.
The honest caveats: most human data are small, open-label, and industry-funded; EGF and most growth factors are large proteins (~6 kDa+) that penetrate intact skin poorly; and because growth factors promote proliferation and angiogenesis, long-term use over sun-damaged skin raises unresolved (though unproven) theoretical safety questions.
So the honest summary: topical growth factors are mechanistically plausible and commercially popular but supported only by weak, partly subjective, industry-leaning evidence. None of this is a health claim.
It is listed under Beauty & Appearance so it is discoverable, but is sandboxed out of ingestible-supplement stacks and the schedule optimizer; it carries a cosmetic badge and a topical-only disclaimer.
Growth factors and cytokines (EGF, TGF-beta, VEGF) normally drive cell proliferation and matrix synthesis in wound healing. Applied to skin, they are proposed to stimulate dermal fibroblasts to produce collagen and elastin — the rationale for 'regenerative' anti-aging serums.
EGF and most growth factors are large proteins (~6 kDa and up) that do not readily cross the intact stratum corneum, casting doubt on whether topically applied growth factors reach living dermal fibroblasts at active concentrations — a key reason real-world effects are uncertain.
No safety data for topical growth-factor cosmeceuticals in pregnancy; discuss with a clinician and consider better-studied actives.
Use caution — growth factors promote cell proliferation/angiogenesis; avoid over suspicious lesions and consult a dermatologist.
Retinoids and vitamin C have far stronger evidence; growth-factor serums are plausible but weakly supported.
Generally layers with other actives; combining many can irritate sensitive skin. Not a systemic interaction — it is not ingested.
Tip: Discontinue if irritation occurs.
Tip: Theoretical, unproven concern; avoid applying over suspicious/precancerous lesions and have skin changes evaluated.
Growth Factors (topical) has an evidence score of 3/10 — emerging evidence based on 6 indexed studies. 'Regenerative' anti-aging serums built around growth factors and cytokines (from human fibroblast cultures, EGF, or snail/plant sources) applied to the skin. The honest framing: growth factors genuinely stimulate fibroblasts and collagen, and small studies report modest wrinkle/texture improvements — but the evidence is weak. The strongest synthesis (a 33-study review) found three head-to-head RCTs with no significant benefit over control, the human trials are mostly small, open-label, and manufacturer-funded, and these are large proteins that may not penetrate intact skin. Biologically plausible, commercially popular, but only low-grade and partly subjective support. Representative study: PMID 37222303.
The commonly studied dose of Growth Factors (topical) is Topical cosmetic only. Growth-factor serums/creams are applied to clean skin once or twice daily per the product. Formulations and growth-factor sources vary widely and are unstandardized, and penetration of large proteins through intact skin is uncertain. There is no oral or systemic dose. This library does not provide an ingestion protocol.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Growth Factors (topical) — consistent daily use matters more than the time of day. Growth-factor serums are leave-on cosmetics with no meal-timing relationship; product formulation and (uncertain) penetration matter more than timing.
Growth Factors (topical) is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are unknown long-term effects (proliferation/angiogenesis), mild local irritation. Use caution if any of these apply to you: For topical (skin) use only — not for ingestion, not for injection; Known allergy or sensitivity to the formulation; Caution over lesion-prone or actively cancerous/precancerous skin (growth factors promote proliferation — theoretical concern).
Sunscreen (SPF)
Mostly mechanism / observationalDaily broad-spectrum sunscreen — the single most evidence-based anti-aging skincare step there is, and the one most 'anti-aging' actives are really just trying to compensate for. The honest framing: this is the only topical on this list backed by a proper randomized controlled trial for skin aging itself. In the landmark Hughes 2013 trial (n=903), people randomized to daily sunscreen showed 24% less photoaging over 4.5 years — and no detectable increase in skin aging at all — while the mechanism (UV → matrix-metalloproteinase activation → collagen breakdown) is textbook. The same trial cohort also had less skin cancer. The honest caveats: the benefit is overwhelmingly prevention, not reversal of existing damage; real-world results depend entirely on applying enough and reapplying; and chemical (organic) UV filters are systemically absorbed above an FDA testing threshold (clinical significance unknown — mineral zinc-oxide/titanium-dioxide filters sidestep this). If you do one thing for your skin, it's this.
Collagen
Likely helpsHydrolyzed peptides that rebuild skin elasticity, reduce joint pain, and strengthen bone density — results build over 8-12 weeks.
Tretinoin (Retin-A)
Mostly mechanism / observationalA prescription TOPICAL retinoid (Retin-A, Renova) — the acid form of vitamin A and the gold-standard, best-evidenced topical treatment for photoaging and acne. Multiple double-blind RCTs show it reduces fine wrinkles, mottled hyperpigmentation, and roughness over months, with histologic increases in dermal collagen. Caveats: retinoid dermatitis (irritation, peeling, dryness), photosensitivity, and it is CONTRAINDICATED IN PREGNANCY. Prescription drug, not a supplement; distinct from weaker OTC 'retinol' cosmetics.
Adapalene
Mostly mechanism / observationalA modern topical retinoid for acne — now available over the counter (0.1%) as well as by prescription (0.3%). A drug, not a supplement or cosmetic. Adapalene is a third-generation retinoid selective for the retinoic-acid receptor beta; it normalizes how skin cells shed (comedolytic) and is anti-inflammatory. The honest framing: this is one of the best-evidenced acne treatments — a 5-trial meta-analysis and a 40-trial network meta-analysis show it matches tretinoin's efficacy with faster onset and notably better tolerability, and the adapalene-benzoyl peroxide combination is among the most effective regimens available. Caveats: it still causes retinoid irritation and slow onset, it is not superior to (only as good as) other retinoids, and — as a retinoid — it is generally avoided in pregnancy.
Explore: Best supplements for Skin, Hair & Beauty
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 6 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.